KRAS and acute lymphoblastic leukemia: Human LMO2+ and Sca1‐Lmo2 T‐ALL showed highly recurrent SNVs and indels in NOTCH1 (p.L1585P) and KRAS (p.G12D/V; Table 1), targeting the same amino acid.